Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: Clinicopathological Characteristics of HCC Patients

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques: Expressing

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: The mRNA and protein expression of TASP1 in HCC cell lines, HCC tissues and the adjacent tissues.

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques: Expressing

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: The Immunohistochemical staining of TASP1 expression in HCC tissues and survival curve.

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques: Immunohistochemical staining, Staining, Expressing

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: Association Between TASP1 Expression and Clinicopathological Characteristics of Patients

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques: Expressing

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: Univariate and Multivariate Analysis of Various Prognostic Parameters in Patients with HCC

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques:

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: TASP1 transcription in hepatocellular carcinoma (Oncomine).

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques:

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: TASP1 expression in hepatocellular carcinoma (HCC) (UALCAN).

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques: Expressing

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: The methylation modification of TASP1 promoter in HCC.

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques: Methylation, Modification

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: The survival outcome of TASP1 in HCC.

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques:

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: Visual summary of TASP1 alterations in HCC (cBioPortal).

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques:

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: The co-expression genes of TASP1 in HCC.

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques: Expressing

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: Biological function of TASP1 correlated genes in HCC (LinkedOmics).

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques:

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: The Kinase, miRNA and Transcription Factor-Target Networks of TASP1 in Hepatocellular Carcinoma (LinkedOmics)

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques:

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: Analysis of TASP1 related proteins based on PPI network (STRING).

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques:

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: Correlation of TASP1 expression with immune cell infiltration in HCC (TIMER).

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques: Expressing

Journal: Cancer Management and Research

Article Title: Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

doi: 10.2147/CMAR.S296069

Figure Lengend Snippet: Correlation analyses between dysregulated TASP1 and cancer-related immune factor in HCC (TISIDB).

Article Snippet: Western blotting was performed using antibodies against TASP1 (1: 1000; #16739‐1‐AP; Proteintech), GAPDH (1: 25000; #60004‐1‐lg; Proteintech) and then with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher, USA) for 1 hr at room temperature.

Techniques: